SRF and breast carcinoma: As it has been demonstrated that the MKL1-SRF/IL-11 signaling is essential for miR-206 function in regulating breast cancer stem cells and tumorigenesis, analyzing this pathway may lead to innovative drug development to control cancer growth and prevent metastasis [90].